UniProt ID | PPIH_HUMAN | |
---|---|---|
UniProt AC | O43447 | |
Protein Name | Peptidyl-prolyl cis-trans isomerase H | |
Gene Name | PPIH | |
Organism | Homo sapiens (Human). | |
Sequence Length | 177 | |
Subcellular Localization | Nucleus speckle . Cytoplasm . Colocalizes with spliceosomal snRNPs. A small proportion may also be cytoplasmic. | |
Protein Description | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. [PubMed: 20676357 Participates in pre-mRNA splicing. May play a role in the assembly of the U4/U5/U6 tri-snRNP complex, one of the building blocks of the spliceosome. May act as a chaperone.] | |
Protein Sequence | MAVANSSPVNPVVFFDVSIGGQEVGRMKIELFADVVPKTAENFRQFCTGEFRKDGVPIGYKGSTFHRVIKDFMIQGGDFVNGDGTGVASIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQFFITCSKCDWLDGKHVVFGKIIDGLLVMRKIENVPTGPNNKPKLPVVISQCGEM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAVANSSPV ------CCCCCCCCC | 14.77 | 25944712 | |
6 | Phosphorylation | --MAVANSSPVNPVV --CCCCCCCCCCCEE | 26.70 | 28464451 | |
7 | Phosphorylation | -MAVANSSPVNPVVF -CCCCCCCCCCCEEE | 32.45 | 28464451 | |
10 | Ubiquitination | VANSSPVNPVVFFDV CCCCCCCCCEEEEEE | 27.34 | - | |
18 | Ubiquitination | PVVFFDVSIGGQEVG CEEEEEEEECCEEEC | 19.84 | 21890473 | |
27 | Ubiquitination | GGQEVGRMKIELFAD CCEEECCEEEEEEEE | 4.16 | - | |
28 | Ubiquitination | GQEVGRMKIELFADV CEEECCEEEEEEEEE | 31.50 | - | |
38 | Acetylation | LFADVVPKTAENFRQ EEEEECHHHHHHHHH | 49.08 | 25825284 | |
38 | Succinylation | LFADVVPKTAENFRQ EEEEECHHHHHHHHH | 49.08 | 27452117 | |
38 | Sumoylation | LFADVVPKTAENFRQ EEEEECHHHHHHHHH | 49.08 | - | |
38 | Ubiquitination | LFADVVPKTAENFRQ EEEEECHHHHHHHHH | 49.08 | - | |
38 | Sumoylation | LFADVVPKTAENFRQ EEEEECHHHHHHHHH | 49.08 | - | |
44 | Methylation | PKTAENFRQFCTGEF HHHHHHHHHHHCCCC | 40.00 | 115488339 | |
52 | Methylation | QFCTGEFRKDGVPIG HHHCCCCCCCCCEEC | 31.67 | 115488333 | |
53 | Ubiquitination | FCTGEFRKDGVPIGY HHCCCCCCCCCEECC | 65.24 | - | |
58 | Ubiquitination | FRKDGVPIGYKGSTF CCCCCCEECCCCCHH | 9.77 | 21890473 | |
58 | Acetylation | FRKDGVPIGYKGSTF CCCCCCEECCCCCHH | 9.77 | - | |
60 | Phosphorylation | KDGVPIGYKGSTFHR CCCCEECCCCCHHHH | 16.94 | 20873877 | |
61 | Ubiquitination | DGVPIGYKGSTFHRV CCCEECCCCCHHHHH | 40.97 | 21906983 | |
61 | Acetylation | DGVPIGYKGSTFHRV CCCEECCCCCHHHHH | 40.97 | 25953088 | |
63 | Phosphorylation | VPIGYKGSTFHRVIK CEECCCCCHHHHHHH | 24.61 | 20873877 | |
64 | Phosphorylation | PIGYKGSTFHRVIKD EECCCCCHHHHHHHH | 31.93 | 20873877 | |
70 | Ubiquitination | STFHRVIKDFMIQGG CHHHHHHHHHEEECC | 41.90 | 21906983 | |
85 | Phosphorylation | DFVNGDGTGVASIYR CCCCCCCCCEEEEEE | 32.97 | 22468782 | |
89 | Phosphorylation | GDGTGVASIYRGPFA CCCCCEEEEEECCCC | 20.11 | 22468782 | |
94 | Ubiquitination | VASIYRGPFADENFK EEEEEECCCCCCCCE | 16.56 | - | |
100 | Ubiquitination | GPFADENFKLRHSAP CCCCCCCCEECCCCC | 8.09 | - | |
101 | Ubiquitination | PFADENFKLRHSAPG CCCCCCCEECCCCCC | 57.08 | 21890473 | |
101 | Acetylation | PFADENFKLRHSAPG CCCCCCCEECCCCCC | 57.08 | 23954790 | |
110 | Ubiquitination | RHSAPGLLSMANSGP CCCCCCHHHHCCCCC | 4.00 | - | |
118 | Phosphorylation | SMANSGPSTNGCQFF HHCCCCCCCCCCCEE | 37.72 | 22210691 | |
119 | Phosphorylation | MANSGPSTNGCQFFI HCCCCCCCCCCCEEE | 38.47 | 22210691 | |
121 | Ubiquitination | NSGPSTNGCQFFITC CCCCCCCCCCEEEEE | 13.49 | - | |
131 | S-nitrosylation | FFITCSKCDWLDGKH EEEEECCCCCCCCCC | 2.33 | 19483679 | |
131 | S-nitrosocysteine | FFITCSKCDWLDGKH EEEEECCCCCCCCCC | 2.33 | - | |
137 | Acetylation | KCDWLDGKHVVFGKI CCCCCCCCCEEEEEE | 32.66 | 26051181 | |
137 | Ubiquitination | KCDWLDGKHVVFGKI CCCCCCCCCEEEEEE | 32.66 | - | |
143 | Ubiquitination | GKHVVFGKIIDGLLV CCCEEEEEEECCCEE | 25.64 | - | |
153 | Ubiquitination | DGLLVMRKIENVPTG CCCEEEEEEECCCCC | 35.95 | 21906983 | |
153 | Acetylation | DGLLVMRKIENVPTG CCCEEEEEEECCCCC | 35.95 | 26051181 | |
159 | Phosphorylation | RKIENVPTGPNNKPK EEEECCCCCCCCCCC | 62.07 | 26657352 | |
164 | Ubiquitination | VPTGPNNKPKLPVVI CCCCCCCCCCCCEEE | 50.61 | 2190698 | |
166 | Acetylation | TGPNNKPKLPVVISQ CCCCCCCCCCEEEEE | 68.01 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PPIH_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PPIH_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPIH_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NH2L1_HUMAN | NHP2L1 | physical | 16723661 | |
PPIH_HUMAN | PPIH | physical | 16723661 | |
PRPF3_HUMAN | PRPF3 | physical | 16723661 | |
PRP4_HUMAN | PRPF4 | physical | 16723661 | |
PRP31_HUMAN | PRPF31 | physical | 16723661 | |
PRP4_HUMAN | PRPF4 | physical | 22939629 | |
PRP4_HUMAN | PRPF4 | physical | 22365833 | |
BAG2_HUMAN | BAG2 | physical | 22365833 | |
ITPA_HUMAN | ITPA | physical | 26344197 | |
PRPF3_HUMAN | PRPF3 | physical | 27173435 | |
PRP4_HUMAN | PRPF4 | physical | 27173435 | |
LSM8_HUMAN | LSM8 | physical | 27173435 | |
THOC4_HUMAN | ALYREF | physical | 27173435 | |
SART3_HUMAN | SART3 | physical | 27173435 | |
LSM4_HUMAN | LSM4 | physical | 27173435 | |
LSM6_HUMAN | LSM6 | physical | 27173435 | |
RL26L_HUMAN | RPL26L1 | physical | 27173435 | |
OLA1_HUMAN | OLA1 | physical | 27173435 | |
RL32_HUMAN | RPL32 | physical | 27173435 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00172 | L-Proline |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-38, AND MASS SPECTROMETRY. |